Home Lilly must divest Sentinel products after FTC nod on Novartis deal
 

Keywords :   


Lilly must divest Sentinel products after FTC nod on Novartis deal

2014-12-22 19:44:54| Biotech - Topix.net

Eli Lilly and Co has won approval to buy Novartis AG's animal health unit on condition that it divests its Sentinel line of products for treating heartworm in dogs, the Federal Trade Commission said on Monday. The French company Virbac SA will buy the Sentinel product line now owned by Novartis Animal Health, the FTC said.

Tags: products deal nod lilly

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
19.05IT Cosmetics and Kenvue Launch New Products
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
19.05 Dr. Squatch Launches Bronco Bricc
19.05Gillette Venus Announces Ambassadors Ahead of the Olympic and Paralympic Games Paris 2024
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
More »